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We aimed to investigate the role of perinatal determinants on the risk for germ-cell testicular cancer, with respect to the
aetiological heterogeneity between seminomas and non-seminomas. A case–control study of 628 case patients with testicular
cancer (308 seminomas and 320 non-seminomas) and 2309 individually matched controls was nested within a cohort of boys
born from 1920 to 1980 in two Swedish regions (Uppsala-O ¨ rebro Health Care Region and Stockholm). Cases were
diagnosed from 1958 to 1998 and were identiﬁed through the Swedish National Cancer Registry. Perinatal information on
cases and controls was collected through charts available at maternity wards. Gestational duration, categorised in three
categories (537, 37–41, 441 weeks), was negatively associated with the risk for testicular cancer (P value for linear
trend=0.008). A protective effect of long gestational duration and an increased risk for high birth weight were found for
seminomas. Non-seminomas were associated with short gestational duration, particularly among those with low birth order
(odds ratio: 3.02, 95% conﬁdence intervals: 1.53–5.97) and high maternal age (odds ratio: 2.33, 95% conﬁdence intervals:
1.19–4.55). No signiﬁcant differences were found in tests for heterogeneity between the two histological groups. Our data
support the hypothesis that intrauterine environment affects the risk for germ-cell testicular cancer. Seminomas and non-
seminomas seemed to have similar risk patterns, although they are not entirely congruent.
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Testicular cancer is the most common neoplasm among young
adults, with a peak of occurrence among males aged 30 years.
The incidence varies 10-fold between countries (Adami et al,
1994) and has been increasing markedly in several populations in
the last 50 years (Schottenfeld, 1996; Moller, 2001; Power et al,
2001). The trend is a birth cohort phenomenon rather than a
calendar period or age effect (Bergstrom et al, 1996; Davies,
1981; Liu et al, 2000).
Undescended testis is the only established risk factor apart from
heredity and genetic disorders, and the pattern of occurrence of
testicular cancer indicates that prenatal life is a critical window
for susceptibility to carcinogenic exposures (Henderson et al,
1979; Sharpe and Skakkebaek, 1993; Ekbom, 1998). A number of
studies have investigated the role of different indicators of prenatal
and perinatal exposures, referring to the hypothesis that the risk for
germ-cell testicular cancer is associated with the levels of sex
hormones during gestation (Schottenfeld et al, 1980; Depue et al,
1983; Brown et al, 1986; Moss et al, 1986; Swerdlow et al, 1987a;
Akre et al, 1996; Moller et al, 1996; Moller and Skakkebaek,
1997; Petridou et al, 1997; Sabroe and Olsen, 1998; Wanderas et
al, 1998; Weir et al, 2000; Dieckmann et al, 2001). Birth order,
duration of gestation, birth weight, nausea and bleeding during
pregnancy, neonatal jaundice, placental weight and maternal age
have been reported as risk factors for testicular cancer by at least
one paper, but there is a marked inconsistency.
Most of the studies on testicular cancer have treated the
neoplasm as a single entity, while few of them conducted analyses
separated by the two major histological groups: seminoma and
non-seminoma (Moss et al, 1986; Swerdlow et al, 1987a; Akre et
al, 1996; Moller et al, 1996; Moller and Skakkebaek, 1997;
Wanderas et al, 1998; Weir et al, 2000). In general, results on aetio-
logical heterogeneity between the two types of testicular cancer
have not been consistent.
In this study we have combined data from the Swedish Cancer
Registry with information from maternity ward charts to perform a
nested case–control study of perinatal factors in relation to risk for
testicular cancer. The study is an enlargement of a previous inves-
tigation (Akre et al, 1996), and the aim was to increase statistical
power in order to enable separate studies of testicular seminomas
and non-seminomas.
MATERIALS AND METHODS
Study population
We conducted a case–control study nested in a cohort of males
born in Sweden from 1920 to 1980 and still alive and resident in
the country at 1 January 1958, when the National Cancer Registry
was established. Subjects included in the cohort were delivered at
hospitals in Uppsala-O ¨rebro Health Care Region as well as in the
city of Stockholm. The cohort is estimated to include the majority
of all males delivered among residents in the catchments area of
the hospitals in 1920–1940 and close to 100% hereafter, as home
deliveries were rare events after 1940.
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www.bjcancer.comCases of malignant germ-cell testicular cancer (code 178 in the
International Classiﬁcation of Diseases, 7th Revision) were identi-
ﬁed through the National Cancer Registry, that includes all newly
diagnosed malignant neoplasms in Sweden from January 1958.
They were diagnosed from 1958 to 1996, with the exception of
subjects born in Uppsala-O ¨rebro Health Care Region, for whom
the period of follow-up ended in 1994.
Patients are listed in the Cancer Registry according to the
national registration number (NRN) that was assigned to all resi-
dents in Sweden since 1947. NRN is a unique personal identiﬁer
containing information on date and county of birth for subjects
born 1947 onwards, or county of residence at 1947 for those born
before that (Lunde et al, 1980).
The NRN allowed us to select testicular cancer patients with
the code for any of the six counties of Uppsala-O ¨rebro Health
Care Region as well as for the city of Stockholm. Underascer-
tainment of cases could only occur for individuals who move
out of their county of birth before 1947 or emigrated before
being diagnosed with testicular cancer. Among potentially eligible
subjects we selected those born in one of the hospitals that
deﬁned the cohort.
We identiﬁed 670 cases through the Cancer Registry. Among
them, nine twins were excluded because twin pregnancies are asso-
ciated with an altered foetal environment and, due to small
numbers, it was not possible to adjust for twin status in the analy-
sis. Seventeen subjects aged less then 15 years or more than 54
years at the time of diagnosis were also excluded as testicular
cancer occurring before puberty or at old age can involve different
etiological factors and pathologic mechanisms.
Information from the National Cancer Registry allowed us to
assign cases to one of the two major groups of testicular
cancer: seminoma and non-seminoma. The latter included
cancers of mixed histological pattern. Tumours with a histo-
pathologic code indicating origin other than germ cells were
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Table 1 Characteristics of cases and individually matched controls and odds ratio of germ-cell testicular cancer for prenatal and
perinatal characteristics
Seminomas Non-seminomas All testicular cancers
Cases Controls Cases Controls Cases Crude Adjusted OR
Characteristic
c (n=308) (n=1111) (n=320) (n=1198) (n=628) OR
a,b (95% CI)
a,b
Subject age (years)
a
mean (s.d.) 34.6 (7.2) 34.3 (7.1) 27.8 (7.2) 27.6 (7.0) 31.1 (8.0)
No. (% of the total)
Maternal age (years)
520 15 (4.9) 66 (5.9) 25 (7.8) 76 (6.3) 40 1.00 1.00
20–24 76 (24.7) 287 (25.8) 89 (27.8) 326 (27.2) 165 0.94 1.02 (0.67–1.54)
25–29 88 (28.6) 359 (32.3) 95 (29.7) 376 (31.4) 182 0.86 0.90 (0.59–1.37)
30–34 82 (26.6) 243 (21.9) 67 (20.9) 262 (21.9) 149 1.03 1.16 (0.74–1.81)
35–39 39 (12.7) 115 (10.4) 32 (10.0) 137 (11.4) 71 0.99 1.06 (0.65–1.73)
40+ 8 (2.6) 41 (3.7) 12 (3.8) 21 (1.8) 20 1.16 1.22 (0.62–2.38)
Each 5-years increase 1.03 1.04 (0.95–1.14)
Maternal SES
a
Low 189 (62.6) 707 (64.3) 185 (60.1) 716 (61.9) 374 1.00 1.00
Medium 88 (29.1) 308 (28.0) 97 (31.5) 348 (30.1) 185 1.08 1.13 (0.91–1.41)
High 25 (8.3) 85 (7.7) 26 (8.4) 92 (8.0) 51 1.10 1.22 (0.85–1.74)
Trend: P=0.15
Birth order
Firstborn 147 (47.7) 499 (44.9) 139 (43.4) 480 (40.1) 286 1.14 1.15 (0.93–1.41)
Non-ﬁrstborn 161 (52.3) 612 (55.1) 181 (56.6) 718 (59.9) 342 1.00 1.00
Gestational duration (weeks)
537 17 (6.7) 49 (4.6) 28 (9.0) 59 (5.0) 45 1.45* 1.36 (0.92–1.99)
37–41 235 (78.3) 789 (74.4) 227 (73.2) 880 (75.0) 462 1.00 1.00
441 48 (16.0) 223 (21.0) 55 (17.7) 235 (20.0) 103 0.79 0.77 (0.60–1.00)
Trend: P=0.008
Dimension-for-gestational-age
a
SGA 18 (6.0) 51 (4.8) 15 (4.9) 56 (4.8) 33 1.21 1.27 (0.84–1.92)
Normal 267 (89.0) 973 (91.8) 282 (91.3) 1070 (91) 549 1.00 1.00
LGA 15 (5.0) 36 (3.4) 12 (3.9) 48 (4.1) 27 1.20 1.12 (0.70–1.79)
Birth weight
52500 8 (2.6) 27 (2.4) 18 (5.6) 33 (2.8) 26 1.66* 1.38 (0.81–2.31)
2500–3999 235 (76.3) 880 (79.3) 236 (74.0) 933 (77.9) 471 1.00 1.00
4000+ 65 (21.1) 203 (18.3) 65 (20.4) 232 (19.4) 130 1.18 1.31 (1.04–1.66)
Eclampsia/toxicosis
Yes 3 (1.0) 12 (1.1) 4 (1.3) 10 (0.8) 7 1.19 1.55 (0.63–3.83)
Jaundice
Yes 38 (12.7) 125 (11.5) 41 (12.9) 150 (12.6) 79 1.09 1.09 (0.80–1.49)
Newborn medical problems
Yes 18 (5.8) 63 (5.7) 36 (11.3) 98 (8.2) 54 1.28 1.16 (0.83–1.64)
aOR, odds ratio; CI, conﬁdence interval; SD, standard deviation; SES, socio-economic status; SGA, small-for-gestational-age; LGA, large-for-gestational
age.
bCrude OR adjusted inherently for age and date and place of birth; Adjusted OR includes all variables listed in the table with the exception of birth
weight that was introduced into the model as alternative to dimension-for-gestational-age.
cDue to missing values the number of subjects for socio-
economic status, gestational duration, dimension-for-gestational-age and birth weight sums less than the total. *P50.05.
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British Journal of Cancer (2002) 87(5), 545–550 ã 2002 Cancer Research UKexcluded from the study. Altogether, 628 cases remained for
analysis.
Controls were the ﬁrst four singleton male offspring born at the
same hospital after a case subject. A linkage, based on the NRN,
between our cohort and the Swedish Cancer Registry as well as
the Swedish Death Registry was performed to verify that controls
were alive and without testicular cancer at the time of diagnosis
of the corresponding case. These criteria were met by 2309
controls.
The study was approved by the local ethics committee at Karo-
linska Institutet (n. 00-033).
Exposure information
We collected information available at different maternity wards
and their archives. A standardised chart to record information
about newborns and their parents was introduced in Sweden in
1973. Hospitals included in the study were selected because they
used similar charts before 1973, but the number of available vari-
ables varied over different hospitals and different time periods.
However, the maternity charts were usually carefully ﬁlled in
and missing values rarely occurred once a variable was included
in the chart.
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Table 2 Odds ratio of seminoma and non-seminoma germ-cell testicular cancer for perinatal characteristics
Seminomas Non-seminomas
Crude Adjusted Crude Adjusted
Characteristic OR
a OR
a 95% CI
a OR OR 95% CI Heterogeneity
b
Maternal age, each 5-years increase 1.07 1.11 0.98–1.26 0.98 0.98 0.86–1.10 P=0.18
Maternal SES
a
Low 1.00 1.00 1.00
Medium 1.08 1.08 0.80–1.48 1.08 1.14 0.84–1.55 P=0.65
High 1.11 1.12 0.68–1.85 1.10 1.26 0.76–2.10
Birth order
Firstborn 1.11 1.27 0.94–1.71 1.16 1.09 0.82–1.44
Non-ﬁrstborn 1.00 1.00 P=0.84
Gestational duration (weeks)
537 1.08 0.98 0.53–1.80 1.80* 1.88 1.15–3.09
37–41 1.00 1.00 1.00 1.00 P=0.28
441 0.68* 0.67 0.47–0.97 0.90 0.89 0.63–1.25
Trend: P=0.06 Trend: P=0.04
Dimension-for-gestational-age
a
SGA 1.39 1.48 0.84–2.61 1.04 1.07 0.58–1.95
Normal 1.00 1.00 1.00 1.00 P=0.46
LGA 1.58 1.66 0.85–3.22 0.94 0.83 0.42–1.62
Birth weight
52500 1.10 1.02 0.44–2.40 2.16* 1.79 0.87–3.65
2500–3999 1.00 1.00 1.00 1.00 P=0.38
4000+ 1.23 1.41 1.01–1.96 1.13 1.22 0.88–1.69
aCrude OR, odds ratio adjusted inheritently for age and date and place of birth; Adjusted OR includes all variables in the table with the excep-
tion of birth weight that was introduced in the model as alternative to dimension-for-gestational-age; CI, conﬁdence interval; SES, socio-
economic-status; SGA, small-for-gestational-age; LGA, large-for-gestational-age.
bP value calculated using likelihood ratio test in comparison of
the two groups of cases and matched controls. *P50.05.
Table 3 Odds ratios of seminoma and non-seminoma germ-cell testicular cancer for interaction between different exposure indicators
Gestational Maternal Gestational Maternal
Birth duration OR age duration OR Birth age OR
order (years) Cases (95% CI)
a (years) (years) Cases (95% CI)
a order (years) Cases (95% CI)
a
Seminomas
Firstborn 537 9 1.13 (0.49–2.59) 28+ 537 7 1.55 (0.61–3.92) Firstborn 28+ 48 1.83 (1.12–2.99)
Non-ﬁrstborn 537 8 1.21 (0.51–2.88) 528 537 10 0.87 (0.40–1.89) Non-ﬁrstborn 28+ 116 1.54 (1.02–2.31)
Firstborn 37–41 117 1.39 (1.00–1.93) 28+ 37–41 126 1.39 (1.01–1.92) Firstborn 528 99 1.42 (0.93–2.15)
Non-ﬁrstborn 37–41 118 1.00 528 37–41 109 1.00 Non-ﬁrstborn 528 45 1.00
Non-ﬁrstborn 441 29 0.81 (0.50–1.29) 528 441 23 0.67 (0.40–1.13)
Firstborn 441 19 0.74 (0.42–1.31) 28+ 441 25 0.93 (0.56–1.55)
Non-seminomas
Firstborn 537 18 3.02 (1.53–5.97) 28+ 537 16 2.33 (1.19–4.55) Firstborn 28+ 33 0.86 (0.52–1.43)
Non-Firstborn 537 10 1.07 (0.51–2.23) 528 537 12 1.40 (0.68–2.91) Non-ﬁrstborn 28+ 112 1.35 (0.94–1.94)
Firstborn 37–41 86 0.86 (0.64–1.24) 28+ 37–41 105 0.96 (0.70–1.32) Firstborn 528 106 1.13 (0.80–1.61)
Non-ﬁrstborn 37–41 141 1.00 528 37–41 122 1.00 Non-ﬁrstborn 528 69 1.00
Non-ﬁrstborn 441 27 0.70 (0.44–1.11) 528 441 35 1.11 (0.71–1.73)
Firstborn 441 28 1.07 (0.66–1.75) 28+ 441 20 0.64 (0.37–1.10)
aOR, odds ratio adjusted for age, date and place of birth, gestational duration, dimension-for-gestational-age, maternal socio-economic level and variables reported in the table;
CI, conﬁdence interval.
Perinatal determinants of testicular cancer
L Richiardi et al
547
ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(5), 545–550Variables used in the analysis included maternal age at delivery,
socio-economic status of the mother according to educational and/
or occupational level, maternal parity (deﬁned as number of births
including the present birth), pre-eclampsia or eclampsia during
pregnancy, gestational duration and weight at birth, neonatal jaun-
dice and medical problems of the newborn. Other recorded
variables were not used either because of a large number of missing
values (e.g. placental weight) or because they were not judged to be
biologically plausible risk indicators.
Small- and large-for-gestational-age were computed on the basis
of both weight at birth and gestational duration, according to the
intrauterine growth curves reported by Marsa ￿l et al (1996). The
values corresponding to the mean weight for gestational duration
+2 standard deviations were chosen as a cut-off to deﬁne respec-
tively large- and small-for-gestational-age.
Statistical methods
We estimated odds ratios (ORs) with corresponding 95% conﬁ-
dence interval (CI) using conditional logistic regression (Breslow
and Day, 1980) available in SAS procedure PHREG (SAS Institute
Inc, 1997). All multivariable models, adjusted for age and place of
birth, included maternal age, socio-economic status (three cate-
gories: ‘high’, denoting college education; ‘medium’, white-collar
worker or farm owner without college education; ‘low’, blue-collar
workers), birth order, gestational duration and dimension-for-
gestational-age. Birth weight was introduced in the models as alter-
native to dimension-for-gestational-age to avoid over-adjustment.
Variables were treated as categorical as shown in Table 1. Subjects
with missing information in one or more variables were excluded
from the analyses. If the subject was a case we also excluded the
corresponding set of controls (Breslow and Day, 1980). A miss-
ing-indicator category was used instead for 18 cases (2.9%) and
53 controls (2.3%) with missing socio-economic values (Huberman
and Langholz, 1999).
Most of the analyses were conducted separately for seminomas
(308 cases, 1111 matched controls) and non-seminomas (320 cases,
1198 matched controls). Heterogeneity of results between the two
histological types was tested by comparing the likelihood of the
model with interaction term between histological group and deter-
minant of exposure with the same parameter derived from the
model without interaction term (likelihood ratio test). Variables
were included in the models if they were independent determinants
and/or substantial confounders.
The effect of individual and joint exposure indicators (maternal
age, birth order and gestational duration) was also assessed. In this
analysis maternal age was categorised into two groups according to
the median value of the control distribution: young mothers (528
years old) and old mothers (28+ years old).
RESULTS
Characteristics of cases and individually matched controls are
shown in Table 1. As expected seminoma cases had a higher mean
age at diagnosis compared with non-seminomas. Table 1 also
presents crude and adjusted odds ratios (ORs) for testicular cancer
as a single entity. We found a statistically signiﬁcant negative asso-
ciation with gestational duration (P for linear trend: 0.008), as well
as a signiﬁcant elevated risk for high birth weight.
In Table 2 results are presented stratiﬁed by the two histological
types. There were no statistically signiﬁcant differences between the
two groups (see last column of Table 2). Although gestational
duration showed a negative trend for both histological groups,
we found that short duration of gestation was signiﬁcantly asso-
ciated with non-seminomas (OR: 1.88, 95% CI: 1.15–3.09),
whereas a protective effect of long gestational duration was
conﬁned to seminomas (OR: 0.67, 95% CI: 0.47–0.97). A signiﬁ-
cant positive association was found between high birth weight and
seminoma cases. Furthermore, we found a non-signiﬁcantly
increased risk for non-seminomas among boys with low birth
weight.
As foetal growth and gestational duration are highly interdepen-
dent, we evaluated the joint effect of these variables in a separate
model (data not shown in tables). As compared with those born
normal-for-gestational-age at term, infants born both preterm
(before gestational week 37th) and large-for-gestational-age had a
three-fold risk for testicular seminomas (OR of 3.29, 95% CI:
1.23–8.80; based on eight exposed cases).
Table 3 presents the individual and joint effects of the most
relevant exposures included in the study. Among infants born at
term, we found signiﬁcantly elevated risks for seminomas among
ﬁrstborns (OR: 1.39, 95% CI: 1.00–1.93; column 4) and boys
with older mothers (OR: 1.39, 95% CI: 1.01–1.92; column 8).
High maternal age was associated with an increased risk for semi-
nomas both among ﬁrstborn and non-ﬁrstborn infants and the
effect of maternal age and birth order appeared to be additive
(column 12).
Among boys born preterm, high maternal age as well as low
birth order further increased the risk for non-seminomas (OR of
2.33, 95% CI: 1.19–4.55 and OR of 3.02, 95% CI: 1.53–5.97 for
high maternal age and low birth order respectively; see columns
8 and 4).
DISCUSSION
Contribution, strength and limitation
The present study is one of the largest to investigate the effect of
different indicators of intrauterine exposures on the risk for
germ-cell testicular cancer.
The study was an enlargement of a previous analysis that indi-
cated etiological heterogeneity between the two major histological
groups of testicular cancer (Akre et al, 1996). In the previous
study the risk for seminomas was associated with high birth
and placental weight, while an increased risk for non-seminomas
was found for high maternal socio-economic status, short gesta-
tional duration, neonatal jaundice and low birth weight. Power
limitations, however, hampered conclusive inference on heteroge-
neity. We therefore expanded the geographic base of the study
and collected information on new cases and controls to triple
the study size and increase the power. For instance, our present
study has a power of 80% to detect an interaction ratio between
the ORs estimated in the two histological groups of at least 1.7,
with a signiﬁcant level of 0.05, for a dicothomic variable, such
as birth order. With the same power, the previous study (232
cases and 904 controls) achieved to estimate a signiﬁcant interac-
tion ratio of 2.4. Power calculation on the other variables
produced similar conclusions.
Cases were identiﬁed through registries whose completeness was
close to 100% and controls were selected from the study base in a
randomized fashion.
A misclassiﬁcation in the histological information recorded in
the Cancer Registry between seminomas and non-seminomas
may have occurred to some extent, resulting in a dilution of
our estimates of the etiological differences between the two histo-
logical groups. Some types of non-seminomas, such as mixed
tumours, may have been classiﬁed as seminomas, in particular
up to 1976 when the work of the British Testicular Tumor Panel
introduced a ﬁrst standard in the classiﬁcation system (Pugh,
1976). However, there are reasons to believe that this had only
minor impacts on our results. Firstly, the difference of about 7
years between the mean age at diagnosis of the two types of testi-
cular cancer is in line with results of other studies where the
specimens were subjected to a pathological review (Weir et al,
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British Journal of Cancer (2002) 87(5), 545–550 ã 2002 Cancer Research UK2000). Furthermore, patients aged below 30 years at diagnosis,
which are mostly non-seminomas, had a similar proportion of
non-seminomas when diagnosed before 1976 (74.7% of 79
patients) and when diagnosed after that (73.2% of 213). Stratiﬁed
analyses of those diagnosed after 1976 did not change our results
more than marginally.
Exposure data were prospectively collected. The nested design of
the present study permitted to preserve the validity of cohort
studies. However, some variables had a high proportion of missing
values because of the lack of standardised maternity charts before
1973. These indicators, such as placental weight, were excluded
from the analysis.
Several tests were performed throughout the analyses, introdu-
cing a problem of multiple comparisons. In the present study,
this issue is particularly relevant as there are not strong a-priori
etiological hypotheses to separate the patients by the two groups,
seminomas and non-seminomas. Thus, positive ﬁndings should
be interpreted with caution, either in the frame of previous
evidence or as a suggestion for further investigation.
Testicular cancer as a single entity
Our data supported previous evidence that prenatal and perinatal
exposures play a role in determining the risk for testicular cancer
(Ekbom, 1998). The mechanism may be related to early failures in
the process of differentiation of germ cells generating carcinomas
in situ of the testis that can develop in testicular cancers during
adult life (Dieckmann and Skakkebaek, 1999). The causal factors
of testicular cancer are largely unknown. However it has been
suggested that the risk may be increased by foetal exposure to
both endogenous and exogenous oestrogens (Henderson et al,
1979; Sharpe and Skakkebaek, 1993). Several case–control studies,
a few animal studies (Walker et al, 1990) and some investigations
on foetal exposure to exogenous hormones (e.g. diethylstilbestrol
(Strohsnitter et al, 2001)) lend indirect support for this hypoth-
esis.
Results on gestational duration (negative association) and birth
weight (u-shaped trend) from this study can be interpreted both
in terms of oestrogen exposure and of foetal growth retardation
or placental malfunction. Some previous studies found similar
results for at least one of the two variables (Depue et al, 1983;
Brown et al, 1986; Moller et al, 1996; Moller and Skakkebaek,
1997; Weir et al, 2000), but the inconsistency is marked. Since
gestational duration and birth weight are strongly correlated, it
is difﬁcult to disentangle the effects of these two aspects of the
intrauterine growth. However, we could estimate the risk for
being small- and large-for-gestational-age because information
on a large number of cases was available. As a result, it was found
that the duration of gestation is a stronger predictor than birth
weight.
One of the most frequently reported ﬁndings in previous studies
is the increased risk of testicular cancer among ﬁrstborn infants
(Depue et al, 1983; Swerdlow et al, 1987a; Prener et al, 1992;
Moller and Skakkebaek, 1997; Sabroe and Olsen, 1998; Wanderas
et al, 1998; Weir et al, 2000). We also found an increased risk,
although not statistically signiﬁcant.
In our previous study jaundice was found to be associated with
an increased risk for testicular cancer, in particular for non-semi-
nomas (Akre et al, 1996). Since then a Norwegian study has
reported the same ﬁnding, using prospectively collected data
(Wanderas et al, 1998). We could not conﬁrm this association in
the present study. However, the diagnosis of neonatal jaundice is
based on symptomatic characteristics and the propensity to make
the diagnosis have varied over different regions and periods. The
high prevalence of jaundice among cases and controls in our study
indicates low speciﬁcity and thus the lack of association may be
due to a non-differential misclassiﬁcation.
Heterogeneity between seminomas and non-seminomas
The classiﬁcation of germ-cell testicular cancer into seminoma and
non-seminoma has a well established prognostic relevance. Despite
the two histological types differing by about 10 years in the mean
age at diagnosis, they show similar trends in incidence. Thus, it has
been suggested that the aetiological heterogeneity is unlikely to be
large (Moller, 1993), although a recent Canadian study found some
differences between the two groups in the birth cohort pattern of
the increase in incidence (Liu et al, 2000).
Some case–control studies conducted analysis separated by
seminomas and non-seminomas (Moss et al, 1986; Swerdlow et
al, 1987a,b; Prener et al, 1992; Akre et al, 1996; Moller and Skak-
kebaek, 1996, 1997; Sabroe and Olsen, 1998; Wanderas et al, 1998;
Coupland et al, 1999; Weir et al, 2000), but results were not consis-
tent and only part of them were in favour of etiological
heterogeneities (Moss et al, 1986; Swerdlow et al, 1987a,b; Akre
et al, 1996; Coupland et al, 1999). Most of these previous studies
included a limited number of subjects with a little power to
perform subgroup analyses.
In spite of the size of our enlarged study we could not ﬁnd any
statistically signiﬁcant heterogeneity between seminomas and non-
seminomas. However, tests for heterogeneity imply a multiplicative
model and ruling out differences on the base of a formal test would
be excessively conservative (Greenland and Rothman, 1998).
Furthermore, the use of proxy variables such as birth order and
foetal growth introduces distortion that may hide differences with
respect to the ‘true’ exposures.
We investigated the effect of the interaction between different
perinatal factors in analysis separated by the two histological groups.
Seminomas were associated with high birth weight, in particular
among preterm boys, and we found an additive effect between
maternal age and birth order. These results are consistent with some
previous studies that indicated at least one of the latter two variables
as risk factors conﬁned to seminomas (Swerdlow et al, 1987a; Prener
et al, 1992; Moller and Skakkebaek, 1997; Sabroe and Olsen, 1998;
Weir et al, 2000). Furthermore, both an English (Swerdlow et al,
1987a) and a Danish (Moller and Skakkebaek, 1997) study observed
a high risk for testicular cancer among ﬁrstborn sons of older
women. However, a recent study found an excess of seminomas
and non-seminomas among ﬁrstborns of mothers aged less than
25 years, which is not consistent with our results (Weir et al, 2000).
Since variables that we examined in our study are only indica-
tors of some unknown risk factors, possibly hormonal, any
hypothesis on the underlying aetiological mechanism is tentative.
Indicators for high levels of maternal oestrogens during pregnancy,
such as high birth weight (Kaijser et al, 2000), being ﬁrstborn
(Bernstein et al, 1986) and intermediate maternal age (Panagioto-
poulou et al, 1990) have been associated with an increased risk
for seminomas (Akre et al, 1996). Intrauterine growth retardation
on the other hand has been seen as a proxy for low oestrogen levels
and has been associated with an increased risk for non-seminomas
(Akre et al, 1996). The association between premature birth and
risk for non-seminomas that we found in our study is in line with
this hypothesis. However, this study failed to put in evidence a
signiﬁcant difference between the two histological groups, suggest-
ing that the etiological heterogeneity, if it exists, is not
straightforward. The effect of short gestational duration on non-
seminomas was positively modiﬁed by both low birth order and
high maternal age. Hence, a more complex etiological mechanism
related to the interaction between different perinatal exposures
may have an effect on determining the type of germ-cell tumour.
Conclusions
In conclusion, our results support the hypothesis that the intrau-
terine environment affects the risk for germ-cell testicular cancer.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(5), 545–550Seminomas and non-seminomas seemed to have similar risk
patterns, although different patterns appear for the two histological
groups with respect to interaction between different perinatal expo-
sures.
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